PF-08049820, PF-08049820, Placebo for PF-08049820
C6231002
Phase 2 small_molecule active
Quick answer
PF-08049820, PF-08049820, Placebo for PF-08049820 for Atopic Dermatitis is a Phase 2 program (small_molecule) at Pfizer Ireland Pharmaceuticals Unlimited Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer Ireland Pharmaceuticals Unlimited Company
- Indication
- Atopic Dermatitis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active